JP2025502943A5 - - Google Patents

Info

Publication number
JP2025502943A5
JP2025502943A5 JP2024539810A JP2024539810A JP2025502943A5 JP 2025502943 A5 JP2025502943 A5 JP 2025502943A5 JP 2024539810 A JP2024539810 A JP 2024539810A JP 2024539810 A JP2024539810 A JP 2024539810A JP 2025502943 A5 JP2025502943 A5 JP 2025502943A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
heterocycloalkyl
haloalkyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024539810A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025502943A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/073579 external-priority patent/WO2023143520A1/en
Publication of JP2025502943A publication Critical patent/JP2025502943A/ja
Publication of JP2025502943A5 publication Critical patent/JP2025502943A5/ja
Pending legal-status Critical Current

Links

JP2024539810A 2022-01-28 2023-01-28 エクトヌクレオチドピロホスファターゼ-ホスホジエステラーゼ1(enpp1)阻害剤およびその使用 Pending JP2025502943A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN2022074739 2022-01-28
CNPCT/CN2022/074739 2022-01-28
CNPCT/CN2022/140318 2022-12-20
CN2022140318 2022-12-20
PCT/CN2023/073579 WO2023143520A1 (en) 2022-01-28 2023-01-28 Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2025502943A JP2025502943A (ja) 2025-01-30
JP2025502943A5 true JP2025502943A5 (cg-RX-API-DMAC7.html) 2026-02-04

Family

ID=87470622

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024539810A Pending JP2025502943A (ja) 2022-01-28 2023-01-28 エクトヌクレオチドピロホスファターゼ-ホスホジエステラーゼ1(enpp1)阻害剤およびその使用

Country Status (12)

Country Link
US (1) US20250101019A1 (cg-RX-API-DMAC7.html)
EP (1) EP4469456A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025502943A (cg-RX-API-DMAC7.html)
KR (1) KR20240142481A (cg-RX-API-DMAC7.html)
CN (1) CN118871439A (cg-RX-API-DMAC7.html)
AR (1) AR128383A1 (cg-RX-API-DMAC7.html)
AU (1) AU2023213905A1 (cg-RX-API-DMAC7.html)
CA (1) CA3247162A1 (cg-RX-API-DMAC7.html)
IL (1) IL313821A (cg-RX-API-DMAC7.html)
MX (1) MX2024009216A (cg-RX-API-DMAC7.html)
TW (1) TW202340190A (cg-RX-API-DMAC7.html)
WO (1) WO2023143520A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024074128A1 (en) * 2022-10-08 2024-04-11 Insilico Medicine Ip Limited Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and uses thereof
WO2025007955A1 (en) * 2023-07-06 2025-01-09 Insilico Medicine Ip Limited Ectonucleotide pyrophosphatase/phosphodiesterase 1 (enpp1) inhibitor combinations and uses thereof
CN121969621A (zh) * 2023-08-02 2026-05-01 英矽智能科技知识产权有限公司 外核苷酸焦磷酸酶-磷酸二酯酶1 (enpp1)抑制剂的结晶形式及其用途
WO2025026377A1 (en) * 2023-08-02 2025-02-06 Insilico Medicine Ip Limited Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE912874A1 (en) * 1990-08-15 1992-02-26 British Bio Technology Compounds
GB9200209D0 (en) * 1992-01-07 1992-02-26 British Bio Technology Compounds
US6489338B2 (en) * 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
KR101142363B1 (ko) * 2005-06-27 2012-05-21 주식회사유한양행 피롤로피리딘 유도체를 포함하는 항암제 조성물
CA2672327A1 (en) * 2006-11-30 2008-06-05 Genentech, Inc. Aza-indolyl compounds and methods of use
US20160222014A1 (en) * 2013-09-10 2016-08-04 Asana Biosciences, Llc Compounds for regulating fak and/or src pathways
WO2019023635A1 (en) * 2017-07-27 2019-01-31 Stingray Therapeutics, Inc. SUBSTITUTED 3 H-IMIDAZO (4,5-C) PYRIDINE AND 1H-PYRROLO (2,3-C) PYRIDINE SERIES OF A NOVEL ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE-1 (ENPP1) AND STIMULATOR FOR A GENE MODULATOR INTERFERON (STING) AS IMMUNOTHERAPEUTIC AGENTS AGAINST CANCER
CN111732584B (zh) * 2019-03-25 2024-02-27 复旦大学 二芳基取代稠杂环类化合物及其制备方法和在制药中的用途
ES2960987T3 (es) * 2019-04-12 2024-03-07 Riboscience Llc Derivados de heteroarilo bicíclicos como inhibidores de la ectonucleótido pirofosfatasa fosfodiesterasa 1
WO2021061803A1 (en) * 2019-09-23 2021-04-01 Nanjing Zhengxiang Pharmaceuticals Co., Ltd. Phosphodiesterase inhibitors and use
CA3204409C (en) * 2021-01-29 2026-04-28 Txinno Bioscience Inc. Benzotriazole derivative having inhibitory activity against ectonucleotide pyrophosphatase-phosphodiesterase, and use thereof

Similar Documents

Publication Publication Date Title
JP2024520481A5 (cg-RX-API-DMAC7.html)
JP2024539946A5 (cg-RX-API-DMAC7.html)
JP2024541910A5 (cg-RX-API-DMAC7.html)
JP2022545633A5 (cg-RX-API-DMAC7.html)
JP2024514837A5 (cg-RX-API-DMAC7.html)
JP2020169171A5 (cg-RX-API-DMAC7.html)
JP2022511477A5 (cg-RX-API-DMAC7.html)
JP2021527125A5 (cg-RX-API-DMAC7.html)
JP2021527638A5 (cg-RX-API-DMAC7.html)
JP2009524691A5 (cg-RX-API-DMAC7.html)
JP2019034943A5 (cg-RX-API-DMAC7.html)
JP2022137237A5 (cg-RX-API-DMAC7.html)
JP2025503953A5 (cg-RX-API-DMAC7.html)
JP2011520815A5 (cg-RX-API-DMAC7.html)
JP2022533939A5 (cg-RX-API-DMAC7.html)
JP2025507292A5 (cg-RX-API-DMAC7.html)
JP2021514001A5 (cg-RX-API-DMAC7.html)
JP2022533069A5 (cg-RX-API-DMAC7.html)
JP2005523922A5 (cg-RX-API-DMAC7.html)
JP2012526728A5 (cg-RX-API-DMAC7.html)
JP2010510237A5 (cg-RX-API-DMAC7.html)
JP2024542969A5 (cg-RX-API-DMAC7.html)
JP2012519691A5 (cg-RX-API-DMAC7.html)
JP2025507915A5 (cg-RX-API-DMAC7.html)
JP2009536221A5 (cg-RX-API-DMAC7.html)